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Pregnancy is associated with adaptations of the immune response and with changes
in the gutmicrobiota. We hypothesized the gut microbiota are involved in inducing
(part of) the immunological adaptations during pregnancy. To test this hypothesis, we
collected feces from pregnant conventional mice before and during pregnancy (days
7, 14, and 18) and microbiota were measured using 16S RNA sequencing. At day
18, mice were sacrificed and splenic (various Th cell populations) and blood immune
cells (monocyte subsets) were measured by flow cytometry. The data were compared
with splenic and blood immune cell populations from pregnant (day 18) germfree
mice and non-pregnant conventional and germfree mice. Finally, the abundances of
the individual gut bacteria in the microbiota of each conventional pregnant mouse
were correlated to the parameters of the immune response of the same mouse. The
microbiota of conventional mice were significantly different at the end of pregnancy (day
18) as compared with pre-pregnancy (Permanova, p < 0.05). The Shannon index was
decreased and the Firmicutes/Bacteroidetes ratio was increased (Friedman followed
by Dunn’s test, p < 0.05), while abundances of various species (such as Allobaculum
stercoricanis, Barnesiella intestihominis, and Roseburia faecis) were significantly different
at day 18 compared with pre-pregnancy. In pregnant conventional mice, the percentage
of Th1 cells was decreased, while the percentages of Treg cells and Th2 cells were or
tended to be increased vs. non-pregnant mice. In germfree mice, only the percentage of
Th1 cells was decreased in pregnant vs. non-pregnant mice, with no effect of pregnancy
on Treg and Th2 cells. The percentages of monocyte subsets were affected by pregnancy
similarly in conventional and germfree mice. However, the activation status of monocytes
(expression of CD80 and MHCII) was affected by pregnancy mainly in conventional mice,
and not in germfree mice. Correlation (Spearman’s coefficient) of pregnancy affected
microbiota with pregnancy affected immune cells, i.e., immune cells that were only
affected differently in conventional mice and germfreemice, showed 4 clusters of bacteria
and 4 clusters of immune cells, some of these clusters were correlated with each other.
For instance, the microbiota in cluster 1 and 2 (in which there were various short chain
fatty acid producing microbiota) are positively correlated with immune cells in cluster
B, containing Treg cells and Th2 cells. Microbiota and immune cells are affected by
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pregnancy in mice. The different immunological adaptations to pregnancy between
conventional and germfree mice, such as the increase in Treg and tendency to an
increase in Th2 cells in conventional pregnant mice only, may suggest that the microbiota
may play a role in adapting the maternal immune response to pregnancy.
Keywords: pregnancy, gut microbiota, immune response, monocytes, lymphocytes
INTRODUCTION
Pregnancy is characterized by many changes in the immune
response in order to tolerate the semi-allogeneic fetus (1).
Changes are observed in the peripheral immune response as
well as locally at the maternal-fetal interface. At the maternal
fetal interface, there is an increased number of uterine NK
cells and macrophages (2), which are important for placenta
development. Peripherally, the pregnant immune response is
amongst others associated with a shift away from a Th1 immune
response (3, 4) and increased numbers of regulatory T cells
(Treg cells) as well as a decreased number of Th17 cells (5–7).
In the periphery, also changes in the innate immune response
can be found, such as an increased number monocytes and
granulocytes during pregnancy (8, 9). The innate immune
response is further characterized by an increased activation
monocytes and granulocytes (10, 11) and differences in cytokine
production of these cells (9, 12). Moreover, changes in monocyte
subsets can be found during pregnancy (13). Similar changes in
the immune response have been observed in rodents (7).
The mechanisms that induces these changes in immune
responses in pregnancy are only partly understood. Although, the
immunological adaptations are necessary in order to tolerate the
semiallogeneic fetus, semiallogeneity is only partly responsible
for inducing the changes in the maternal immune response,
since changes in the immune response do also occur in mice
with syngeneic pregnancies (14). Hormonal changes during
pregnancy, such as increased progesterone have been shown
to be involved in adapting the maternal immune response
to pregnancy (15). Physical contact with the placenta during
placental circulation may be another mechanism by which innate
immune cells are activated during pregnancy (16). However, it
has also been shown that the placenta produces many factors
into the maternal circulation (17): such as cytokines (18),
extracellular vesicles (19), but also fetal DNA (20) may affect
immune responses. Other factors suggested to be involved in the
adaptation of the immune response to pregnancy are semen (21)
or ovarian factors (22).
With the recent knowledge on the role of the gut
microbiota in development and maintenance of immune
responses (23), we hypothesized that the gut microbiota may
be involved in inducing (part of) the immunological changes
observed during pregnancy. It has been shown that the gut
microbiota may influence the numbers and activation status
of various immune cells, such as for instance Treg (24)
and Th17 (25) cells. Also, monocyte numbers and their
activational state may be influenced by the microbiota (26).
As indicated above, these immune cells are also affected
by pregnancy. Interestingly, it has been shown that in
humans the gut microbiota changes during pregnancy (27),
while recently, we have shown that also the mouse gut
microbiota changes at the end of pregnancy (14). Moreover,
we have shown that the changes in the mouse gut microbiota
during pregnancy correlated to differences in expression
of immunological changes in the colon (14), suggesting
that the gut microbiota affects intestinal immune responses
during pregnancy.
In the present study, we aimed in evaluating whether the gut
microbiota may also influence the peripheral immune response
during pregnancy. Therefore, we first analyzed changes in the
gut microbiota during pregnancy in conventional mouse by
collecting feces before pregnancy and at days 7, 14, and 18 of
pregnancy. We also evaluated the peripheral immune response
in these pregnant conventional mice at day 18 of pregnancy.
We hypothesized that if some of the peripheral immunological
changes would be induced by the microbiota, these changes
would not be observed in germfree pregnant mice. Therefore,
we also evaluated the peripheral immune response in pregnant
germfree mice and compared this to the immune response in
the conventional pregnant mice. In the present study we used
syngeneic pregnancies, to exclude the effect of semiallogeneity on
the immune response to be able to show effects of the microbiota
more clearly. Finally, we correlated the gut microbiota to




All mice experiment for this study were approved by the Central
Committee for Animal experimentation in The Netherlands and
experiments were performed according to their guidelines. Male
and female wild type conventional C57BL/6JOlaHsd mice were
purchased from Envigo (Envigo, Horst, The Netherlands) at
an age between 2.5 and 3 months. All conventional mice were
cohoused in isolated ventilated cages (5 mice per cage) with a
12-h light,12-h dark cycle. Germfree mice (C57BL/6JOlaHsd)
were bred and nurtured at the Central Animal Facility of the
UMCG. They were kept in germfree isolators until sacrifice and
checked for germfree status regularly by the facility. Germfree
mice were cohoused (5 mice per cage) with a 12-h light,12-h
dark cycle. All (conventional and germfree) mice were provided
with germfree bedding, an irradiated diet, AIN-93M (Research
Diet Services, the Netherlands) and sterile water ad-libitum. The
diet was provided starting at least 3 weeks before pregnancy and
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continuing during pregnancy and 3 weeks before sacrifice in
non-pregnant mice.
After 3-weeks acclimatization in the facility and on the diet,
vaginal smears were taken to check the ovarian cycle of the
mice. When in pro-estrus, the female mice were placed with
male mice overnight. We used syngeneic pregnancies, to exclude
the effect of semiallogeneity on the immune response. The next
morning, mice were checked for a plug or sperm in the smear
and this day is day 0 of pregnancy. For conventional mice, fecal
samples were collected before and during pregnancy (on days 7,
14, and 18; n = 12). These conventional mice were terminated
at day 18 of pregnancy. Germfree pregnant mice (n = 9) were
also terminated at day 18. Two groups of non-pregnant mice [1
group of conventional (n = 12) and 1 group of germfree mice
(n = 11)] were terminated for measuring the immune response
at di-estrus of the ovarian cycle to ensure low levels of estrogen
and progesterone. Termination was done in sterile flow cabinets.
At termination, mice were anesthetized with isofluorane/O2,
and blood was collected from the aorta into EDTA tubes (BD-
Plymouth, UK). After bleeding, spleens were also collected. For
pregnant mice, we counted number of viable fetuses and number
of resorptions and weighed individual placentas and fetuses.
Microbiota Measurement
Immediately after collection, fecal samples were snap frozen
in screw caps in liquid nitrogen and stored at −80◦C until
measurement. For DNA isolation 0.25 gr of fecal sample was
added to a 2ml sterile bead beater tube filled with 1ml of 0.1mm
zirconia/silica beads with 1ml of lysis buffer (5MNaCl, 1M Tris-
HCL (pH= 8); 0.5M EDTA and 10 % SDS). Samples were placed
in a bead beater (Percellys 24, Bertin Instruments, Montigny-
leBretonneux, France) for 3min on 5,500 RPM in three cycles
of 30–60 s. The samples were heated to 95◦C for 15min while
shaking every 5min and put on ice for 5min. Hereafter, the tubes
were centrifuged for 5min at maximum speed to pellet debris.
The supernatant was transferred into a new sterile 2ml tube and
300 µl of fresh lysis buffer was added followed by bead beating,
heating to 95◦C and centrifuged for 5min at maximum speed to
remove any additional debris.
Nucleic acids were cleaned from proteins and cell debris
by precipitation using ammonium acetate (260 µl of 10M
ammonium acetate) on ice for 5min. Tubes were centrifuged
for 10min at full speed at 4◦C. Pellet was discarded and
supernatant was treated a second time with the same procedure,
followed by precipitation of the DNA from the supernatant
with isopropanol on ice for 30min. After centrifugation, the
pellets were washed with ethanol 70% and dried. Hereafter,
genomic DNA purification was performed according to the
protocol of the QIAmp DNA Mini Kit (Qiagen, Benelux,
Venlo, the Netherlands). DNA concentration was measured
with a NanoDrop ND-1000 Spectrophotometer (Thermo Fisher
Scientific, Waltham, MA, USA).
16S rRNA Gene Sequencing, Quality
Control, and Taxonomy Assignment
Subsequently, the DNA was used for the amplification of the
V3–V4 region of the 16S rRNA gene using modified 341F
(AATGATACGGCGACCACCGAGATCT-ACACTCTTT
CCCTACACGACGCTCTTCCGATCT-NNNNCCTAC
GGGAGGCAGCAG) and 806R primers (CAAGCAGAA
GACGGCATACGAGAT-barcode-GTGACTGGAGTTCAGAC
GTGTGCTCTTCCGATCT-GGACTACHVGGGTWTCTAAT)
containing a 6-nucleotide barcode and flow-cell adaptor on the
806R primer as described elsewhere (28). A 2 × 300 cartridge
(Illumina, Eindhoven, the Netherlands) was used to perform
both MiSeq library preparation and sequencing. PCR protocol,
DNA cleanup and the library preparation were all done as
described before (29). Sequence reads with a quality score lower
than 0.9 were discarded by PANDAseq to increase the quality.
QIIME was used to identify sequence reads until the genus levels,
while ARB software (29) was used to identify sequences at the
species level.
Isolation and Staining of Spleen Cells
Cells were isolated from the maternal spleen for immune
cell staining according to methods described before (14). The
spleen was first cut into small pieces, mechanically disrupted
between two microscopy slides in 3ml ice-cold RPMI containing
10% (v/v) heat-inactivated fetal calf serum (FCS). Splenic
red blood cells were eliminated by incubation with 4ml ice-
cold ammonium chloride. Falcon tubes with cell strainer caps
(Corning, Amsterdam, the Netherlands) (35µm) were used to
remove cell clumps before the cells were counted and used
for staining.
All antibodies were diluted and supplemented to a volume of
25 µl with FACS buffer [PBS + 10% FCS (v/v)]. Approximately
1 × 106 spleen cells were incubated in Zombie NIR for 30min.
After washing with FACS buffer (2 times), the supernatant
was discarded and the cells were incubated for 20min in
FACS buffer [10% FCS (v/v)] containing 20% (v/v) normal rat
serum (Jackson, Newmarket, UK) on ice and in the dark, to
prevent non-specific antibody binding. This was followed by
incubation in an extracellular antibody mix for 30min on ice
and in the dark (Table 1). After 2 washing steps, the cells
were fixed in FACS lysing solution (BD Biosciences, Breda, the
Netherlands) for 30min on ice and in the dark. Then cells were
washed twice with permeabilization buffer (eBioscience, Vienna,
Austria) after which they were incubated with an intracellular
blocking medium (20% (v/v) rat serum in permeabilization
buffer) for 20min. After washing, the cells were incubated with
the intracellular antibody mix for 30min on ice and in the
dark (Table 1). This was followed by 2 washing steps with
permeabilization buffer. Finally, the cells were taken up in 200
µl ice-cold 2%(v/v) FACS buffer and stored at 4◦C until analysis
within 24 hrs. FMO controls were used to set the gates.
Staining of Blood Monocytes
Maternal blood was stained for monocytes subsets and activation
status according to an adapted method previously used for rat
studies (13). Antibody specifications are shown in Table 2. Two
hundred microliters of whole blood was diluted with 200 µl
RPMI buffer (500ml RPMI + 50ml decomplemented FCS), and
incubated with 50 µl ice-cold extracellular blocking medium (2%
(v/v) Fc-block (purified anti-mouse CD16/32) (Biolegend, San
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TABLE 1 | Antibody mix for staining of splenic cells.
Marker Fluorchrome Dilution Supplier Mix
CD4 PerCp-Cy5.5 75x Biolegend Extracellular
CD3 BV605 25x Biolegend Extracellular
Tbet BV421 10x Biolegend Intracellular
RORyT PE 100x eBioscience Intracellular
Gata3 AF647 100x BD Pharmingen Intracellular
FoxP3 Fitc 50x eBioscience Intracellular
Dead/live Zombie NIR 1000x Biolegend
TABLE 2 | Antibody mix for staining of blood monocytes.
Marker Fluorochrome Dilution Supplier
MHC2 PerCp-Cy5.5 200x Biolegend
Ly6C AF488 200x Biolegend
CD43 APC 100x Biolegend
CD11b PE 50x Biolegend
CD80 PB 25x Biolegend
Ly6G BV605 25x BD Horizon
Diego, USA) in 10% (v/v) FACS+EDTA buffer) for 10min on
ice in the dark. After centrifugation (1800 RPM, 5min, 4
◦
C) the
supernatant was discarded and the cells were incubated in 25
µl ice-cold antibody mix for 30min on ice in the dark. After
incubation, the cells were incubated with 1ml FACS lysing buffer
for 15min at room temperature in the dark. After washing for
3 times, the cells were taken up in 500 µl ice-cold 10% (v/v)
FACS+EDTA buffer and stored at 4
◦
C until analysis within
24 hrs.
Flow Cytometry
Samples were analyzed by the FACSverse flow cytometer system
(BD Biosciences Franklin Lakes, USA), using the FACSsuite
software. Analysis was performed by FlowJo version 10 software
(FlowJo, LLC, Oregon, USA). Gating strategy was performed as
described in Figures 6A, 7A.
Statistics
For the Shannon index, the PCA, the Permanova and the
similarity percentage breakdown (Simper) test we used Past3
(30). For statistical analysis (Graphpad Prism) of differences in
Shannon index, Firmicutes/Bacteroidetes ratio, bacterial phyla
and species between pre-pregnancy and the days of pregnancy,
we used the Friedman’s test followed by Dunn’s post-test. Data
were considered significantly different when p < 0.05 and
considered a trend if p= between 0.05 and 0.1.
Differences in fetal and placental weight and number of (live)
fetuses between pregnant conventional and germfree mice were
tested using the Mann-Whitney-U test, data were considered
significantly different if p < 0.05.
For testing the effect of pregnancy (pregnant vs. non-pregnant
mice) or the effect of the germfree status (conventional vs.
germfree mice) on immune cells, we used the Two-Way ANOVA
FIGURE 1 | PCA plot representing the gut microbiota of conventional
pre-pregnant (black circles), day 7 (blue circles), day 14 (red circles), and day
18 (green circles) mice. The day of pregnancy (PC2) does explain part of the
variation. PC1 explains 81.42% of the variation, while PC 2 explains 12.47% of
the variation.
(TWA). For this, data were first tested for normality using
the Kolmogorov-Smirnov test. Data that were not normally
distributed were log transformed before the analysis. Post-testing
was performed with Fisher’s LSD post-test. Since we were mainly
interested in the effect of pregnancy, post-tests were only done
on the difference between pregnant and non-pregnant mice in
both conventional and germfree mice. Data were considered
significantly different when p < 0.05.
To gain insight into the relationship between the gut
microbiota and immune cell changes during pregnancy, we
correlated individual microbiota abundances with immune cell
data of the same mice. We correlated individual microbiota that
were changed during pregnancy to individual immune cells that
were affected by pregnancy only in conventional mice using the
spearman’s correlation coefficient. The correlation coefficients
were visualized in clustered heatmaps using Clustvis (31). Cluster
analysis using Euclidian distance and Ward’s clustering method
was performed.
RESULTS
We determined the gut microbiota composition of mice after
longitudinal sampling of feces from 12 conventional mice
starting before pregnancy and at days 7, 14, and 18 of pregnancy.
PCA analysis (Figure 1) showed that PC1 explained about 80%
of the variation and while PC2, mainly represented by day of
pregnancy, explains about 12 % of the variation in our groups.
It can be seen that day 18 of pregnancy is significantly different
from all other groups (Permanova, p < 0.05). Although day 14
of pregnancy also appeared different from pre-pregnancy and
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TABLE 3 | The microbiota species explaining the difference in gut microbiome at day 18 of pregnancy vs. pre-pregnancy.










Allobaculum stercoricanis 29.01 29.01 35.1 52.8 p<0.05
Barnesiella intestinihominis 17.22 46.23 18.4 4.79 p<0.05
Porphyromonas pogonae 3.908 50.13 6.03 3.19 p<0.05
Barnesiella viscericola 3.42 53.55 4.27 1.56 p<0.05
Clostridium leptum 3.295 56.85 1.87 2.95 ns
Faecalitalea cylindroides 1.79 58.64 2.7 3.85 p<0.05
Olsenella profusa 1.728 60.37 2.33 1.27 p<0.05
Lactobacillus johnsonii 1.583 61.95 1.3 0.841 ns
Clostridium papyrosolvens 1.513 63.46 1.45 0.298 p<0.05
Acetatifactor muris 1.486 64.95 0.975 1.05 ns
Flavonifractor plautii 1.444 66.39 0.612 1.29 ns
Clostridium fusiformis 1.375 67.77 0.603 1.34 ns
Parasutterella excrementihominis 1.309 69.08 1.74 1.01 p<0.05
Blautia coccoides 1.293 70.37 0.594 1.09 ns
Romboutsia ilealis 1.245 71.62 0.537 1.18 ns
Eisenbergiella tayi 1.245 72.86 0.505 1.2 ns
Alloprevotella rava 0.9948 73.86 0.957 0.198 p<0.05
Sutterella parvirubra 0.9198 74.78 1.21 0.689 p<0.05
Mucispirillum schaedleri 0.8793 75.65 0.142 0.706 ns
Bifidobacterium animalis 0.8583 76.51 1.16 1.14 ns
Alistipes finegoldii 0.8434 77.36 0.922 0.85 ns
Bifidobacterium pseudolongum 0.7753 78.13 0.81 0.515 ns
Olsenella umbonata 0.7728 78.9 0.897 0.414 ns
Desulfovibrio desulfuricans 0.7725 79.68 0.552 0.656 ns
Butyrivibrio crossotus 0.6543 80.33 0.298 0.287 ns
Bacteroides vulgatus 0.5959 80.93 0.481 0.0983 ns
Roseburia faecis 0.5823 81.51 0.229 0.528 p<0.05
Anaerotruncus colihominis 0.5782 82.09 0.279 0.513 ns
Clostridium jejuense 0.5744 82.66 0.371 0.392 ns
Alistipes senegalensis 0.545 83.21 0.562 0.678 ns
Natronoflexus pectinivorans 0.533 83.74 0.518 0.409 ns
Significance (last column) was tested using Friedman’s tests on all pregnancy days followed by Dunn’s posttest comparing pre-pregnancy with day 18.
from day 7 in the PCA plot, this difference was not statistically
significant (Permanova, p > 0.05).
To identify bacteria that explained the variation between the
pre-pregnancy microbiota and day 18 microbiota, we performed
a Simper test (Table 3). We found that Allobaculum stercoricanis,
which significantly increased at day 18 vs. pre-pregnancy,
explained 29 % of the variation between pre-pregnancy and day
18 of pregnancy. Barnesiella intestinihominis, which significantly
decreased during pregnancy, explained 17% of the variation
between the pre-pregnancy and day 18 microbiota. Various
bacterial species (such as Porphyromonas pogonae, Barnesiella
viscericola, Clostridium leptum) explain between 1 and 3% of the
variation between the pre-pregnancy and day 18 microbiota.
Figure 2 shows the Shannon index and the
Firmicutes/Bacteroidetes ratio before and during pregnancy. It
can be seen that the Shannon index is significantly decreased at
day 18 as compared with pre-pregnancy (Friedman test followed
by Dunn’s posttest). The Firmicutes/Bacteroidetes ratio is
significantly increased at day 18 as compared with pre-pregnancy
(Friedman’s test followed by Dunn’s post-test, p < 0.05), while
a trend toward an increase of the Firmicutes/Bacteroidetes ratio
was seen at day 14 of pregnancy (Friedman test followed by
Dunn’s posttest, p= 0.08).
Figure 3 shows differences in abundances of various bacterial
phyla occurring during pregnancy in the mouse. Significant
changes only occurred at day 18 vs. pre-pregnancy. We found
a significantly increased abundance of Firmicutes at day 18
as compared with pre-pregnancy (Friedman’s test followed
by Dunn’s posttest, p < 0.05), and a significantly decreased
abundance of Bacteroidetes, Actinobacteria, Cyanobacteria and
Proteobacteria at day 18 of pregnancy as compared with
pre-pregnancy (Friedman’s test followed by Dunn’s post-test,
p < 0.05).
Various changes in the microbiota can also be observed
at the species level. Examples of changes at the species
level can be seen in Figure 4. In this figure, examples
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FIGURE 2 | Shannon index (left graph) and Firmicutes/Bacteroidetes ratio (right graph) in the feces of conventional mice measured pre-pregnancy (pre) and at days 7,
14, and 18 of pregnancy (n = 10 at each day). *Significantly different from pre-pregnancy (Friedman’s test, followed by Dunn’s post-test, p < 0.05). t, significant trend
vs. pre-pregnancy (Friedman’s test, followed by Dunn’s post-test, p < 0.1).
FIGURE 3 | Abundance of the bacterial phyla (Firmicutes, Bacteriodetes, Actinobacteria, Cyanobacteria, and Proteobacteria which significantly differ during
pregnancy as compared with pre-pregnancy in the feces of conventional mice measured pre-pregnancy (pre) and during pregnancy at days 7, 14, and 18. Bottom
right graph shows stack bars for pre-pregnancy and the 3 days of pregnancy, showing the percentage abundance of the all bacterial phyla present in the feces of
these mice. (12 conventional mice were longitudinally studied from pre-pregnancy until the end of pregnancy). *Significantly different from pre-pregnancy (Friedman’s
test, followed by Dunn’s post-test, p < 0.05).
of bacterial species showing differences at day 18 of
pregnancy as compared with pre-pregnancy (Friedman’s
test followed by Dunn’s posttest, p < 0.05) are shown.
Various species of the Firmicutes phylum are increased at
day 18 of pregnancy vs. pre-pregnancy, such as Allobaculum
sternicoricanis, Faecalitalea cylindroides, Roseburia faecis,
Eubacteria plexicaudatum, while various other bacterial
species, such as various Bacteroidetes species are decreased
at day 18 of pregnancy vs. pre-pregnancy (Barnesiella
intestinihominis, B viscericola, Alloprevotella rava, and
Odoribacter splanchnicus). Some bacteria (B. intestinihominis, B.
viscericola, C. papysosolvens, and O. splanchnicus) already show
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FIGURE 4 | Changes observed in the abundance of various microbiota species in the feces of conventional mice measured pre-pregnancy (pre) and during
pregnancy at days 7, 14, and 18. *Significantly different from pre-pregnancy (Friedman’s test, followed by Dunn’s post-test, p < 0.05).
significant changes at day 14 of pregnancy as compared with
pre-pregnancy (Friedman’s test followed by Dunn’s post-test,
p < 0.05). A complete list of all changes can be found in
Supplementary Table 1.
Changes in Immune Cells on Pregnancy
Day 18 in Conventional and Germfree Mice
To study the effect of the microbiota on immunological changes
during pregnancy in mice, we sacrificed conventional mice on
day 18 and collected spleens and blood in order to evaluate
lymphocyte subsets in the spleen and monocyte subsets in blood.
We hypothesized that if the gut microbiota would be involved in
the adaptations of the immune response to pregnancy, some of
the adaptations observed in conventional pregnant mice would
not be observed in germfree mice.
Fetal and Placental Weight in Conventional
and Germfree Pregnant Mice
Figure 5 shows that fetal weight is slightly, but significantly
decreased in germfreemice, with no significant effect on placental
weight. Although the total number of fetuses was similar in
conventional and germfree mice, the number of resorptions was
increased in germfree mice, resulting in a significantly decreased
number of live fetuses in germfree mice.
The Effect of Pregnancy on Thelper
Subsets
Figure 6B shows the percentage of Thelper (Th) cells, T-box
transcription factor+ (Tbet) cells (Th1 cells), Gata binding
protein 3+ (Gata3) cells (Th2 cells), Forkhead box P3+
(FoxP3) cells (Treg cells), RAR-related orphan receptor gamma
t+ (RoRgT) cells (Th17 cells) and FoxP3/RoRgT double
positive cells. For Th cells, the Two-Way ANOVA (p < 0.05)
indicated that there was interaction between pregnancy and
the germfree status, indicating that the effect of pregnancy
on Th cells was different in conventional compared with
germfree mice. Post-testing showed an increased percentage of
Th cells in pregnant germfree mice vs. non-pregnant germfree
mice, but no difference in Th cells in pregnant vs. non-
pregnant conventional mice. The percentage of Tbet+ cells is
decreased by pregnancy (TWA, p < 0.05), but not affected
by the germfree status (TWA, p < 0.05). Post testing showed
that in both conventional and germfree pregnant mice the
percentage of Tbet+ cells is decreased as compared with the
percentage of Tbet+ cells in non-pregnant mice. The percentage
of GATA3+ cells is increased in pregnant conventional mice
as compared with non-pregnant conventional mice, but no
difference in percentage of GATA3+ cell was found between
pregnant and non-pregnant germfree mice (TWA followed
by Fisher LSD test, p < 0.05). TWA also showed an effect
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FIGURE 5 | Fetal and placental weight and fetal numbers (living fetuses and total numbers) for conventional day 18 pregnant (conv) and germfree day 18 pregnant
(GF) mice. *Significantly different from conventional mice (Mann-Whitney-U-test, p < 0.05).
of the germfree status, i.e., an increase of GATA3+ cells in
germfree mice.
FoxP3+ cells were affected by both pregnancy (increase) and
the germfree status (decrease). (TWA, p < 0.05). Post testing
revealed a significant increase in percentage FoxP3+ cells in
conventional pregnantmice vs. conventional non-pregnantmice,
but not in pregnant vs. non-pregnant germfree mice. No effect of
pregnancy or the germfree status was observed on RoRgT+ or on
FoxP3/RoRgT double positive cells.
Effect of Pregnancy on Leucocyte Subsets
in Blood
The different leukocyte subsets in the blood are shown in
Figure 7B. TWA showed an interaction between pregnancy
and the germfree status for lymphocytes. Post-testing
showed a significantly decreased percentage of lymphocytes
in germfree pregnant mice as compared with germfree
non-pregnant mice, but no difference in percentage of
lymphocytes in pregnant vs. non-pregnant conventional
mice (TWA followed by Fisher LSD test, p < 0.05). Also,
for monocytes and granulocytes, we found an interaction
between pregnancy and germfree status (TWA, p < 0.05).
Only in germfree mice (Fisher LSD test, p < 0.05), not
in conventional mice, we found a significantly increased
percentage of monocytes and granulocytes in pregnant vs.
non-pregnant mice.
The Effect of Pregnancy on Monocyte
Subsets
It can be observed from Figure 8A that the percentage of classical
monocytes was affected by pregnancy (TWA, p < 0.05); the
percentage of classical monocytes is increased in pregnant mice
as compared with non-pregnant mice, both in conventional and
germfree mice (Fisher LSD test, p < 0.05). Germfree status
also affected the classical monocytes, i.e., classical monocytes
are decreased in germfree mice (TWA, p < 0.05) as compared
with conventional mice. There was no effect of pregnancy on
the percentage of intermediate monocytes, while there was an
effect of germfree status, i.e., in germfree mice the percentage
of intermediate monocytes was increased as compared with
conventional mice (TWA, p < 0.05). Non-classical monocytes
were affected by pregnancy (TWA, p < 0.05); they were
decreased in pregnancy in both conventional and germfree
mice (TWA, followed by Fisher LSD test, p < 0.05). Non-
classical monocytes were also increased by the germfree status
(TWA, p < 0.05).
The Expression of Activation Markers on
Monocytes of Pregnant Mice
CD80 is a costimulatory molecule, which is upregulated on
antigen presenting cells during activation. For both classical
and intermediate monocytes, there was an interaction between
pregnancy and germfree status (TWA, P < 0.05) (Figure 8B).
Post testing showed a significantly increased expression of
CD80 in pregnant vs. non-pregnant mice in both classical and
intermediate monocytes, only in conventional mice (Fisher LSD
test, p < 0.05), not in germfree mice. No effect of pregnancy or
the microbiota status was found on CD80 expression in non-
classical monocytes. (TWA, p < 0.05). MHCII expression of
monocyte subsets was also affected by pregnancy (Figure 8C).
MHCII in classical monocytes was decreased by pregnancy,
both in conventional and germfree mice (TWA, followed by
Fisher LSD test, p < 0.05) (Figure 8C). MHCII expression of
intermediate monocytes was affected by pregnancy and the
germfree status (TWA, P < 0.05). Only in conventional mice, not
in germfree mice, MHCII expression was significantly decreased
as compared with non-pregnant mice. There was no effect of
either pregnancy or the germfree status on MHCII expression on
non-classical monocytes.
Correlation Between Microbiota and
Immune Cells in Conventional Mice
To gain insight into the relationship between the gut microbiota
and immune cell changes during pregnancy in conventional
mice, we correlated individual microbiota abundance data with
immune cell data of the same mice. We used data from
conventional day 18 mice: we used percentages of immune cells
and percentage of immune cells expressing activation markers
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FIGURE 6 | (A) Gating strategy for lymphocyte subsets. First singlets and live cells were selected and copied to the FSC-SSC plot. In this plot, leukocytes were
selected and copied to an SSC-BV605 plot, in which the CD3+ cells were selected. The CD3+ cells were copied to a BV605-PerCP-Cy5.5 plot to selected the CD4+
cells. CD4 positive cells were copied to a BV421-Alexa647 plot (to select Tbet+ cells and Gata3+ cells) and to a FITC-PE plot (to select FoxP3+ cells and RoRgT+
cells). For gate setting of the latter two plots we used FMOs. (B) Percentage of splenic Th cells, Th1 cells, Th2 cells, Treg cells, Th17 cells, and FOXP3/RORgT double
positive cells (within the T cell population) of pregnant and non-pregnant conventional and germfree mice. TWA, Two-way ANOVA. *Significantly different from
non-pregnant mice (TWA followed by Fisher’s LSD post-test, p < 0.05). t: significant trend from non-pregnant mice (TWA followed by Fisher’s LSD post-test, p < 0.1).
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FIGURE 7 | (A) Gating strategy for leukocyte populations and monocytes. In the FSC-SSC plot, we selected the leukocytes, which were copied to the FSC-PE plot to
select CD11b++ cells (myeloid cells). These myeloid cells were copied to an SSC-BV605 plot to discriminate monocytes from granulocytes. Percentages of
monocytes and granulocytes were derived from this plot. Percentage lymphocytes was 100% of myeloid cells. The monocytes were then copied to an Alexa488-APC
plot to discriminate classical, intermediate and non-classical monocytes. Each of these three subsets were then copied to an SSC-PerCPCy5.5, to select MHCII+
cells (example is shown for classical monocytes), using the FMO to set the gates. Each of these monocytes’ subsets were also copied to an SSC-Pacific Blue plot to
select the CD80+ cells, using FMO to set the gates, similar to MHCII (not shown in the figure). (B) Percentage of lymphocytes, monocytes, and granulocytes in whole
blood of pregnant (day 18) and non-pregnant conventional and germfree mice. TWA, Two-way ANOVA. *Significantly different from non-pregnant mice (TWA followed
by Fisher’s LSD post-test, p < 0.05).
that were differently regulated by pregnancy in conventional vs.
germfree mice. For microbiota data we used bacterial species
from conventional mice of which the abundance was different
at day 18 of pregnancy as compared with pre-pregnancy.
Pearson’s correlation coefficients are shown in a heatmap
(Figure 9). Bacteria in cluster 1, of which most bacteria were
upregulated during pregnancy, seem to be positively correlated
with immune cell cluster A and B, which contains percentages
blood granulocytes and percentages intermediate monocytes
expressingMHCII (cluster A) and percentages of splenic FoxP3+
(Treg) and GATA3+ (Th2) cells (cluster B). Bacterial cluster
1 is negatively correlated with immune cell cluster D, which
contains splenic percentages of Th cells and percentages of
blood monocytes and lymphocytes. Bacterial cluster 2, which
contains bacteria that are either upregulated or downregulated
during pregnancy, was also negatively correlated to immune
cells in cluster D and positively correlated to immune cells
in cluster B. Bacteria in cluster 4 are negatively correlated
with immune cells in cluster C, most strongly with percentage
of CD80 expressing intermediate monocytes. Abundances of
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FIGURE 8 | (A) Percentages of monocyte subsets (within the monocyte population) in blood of conventional and germfree pregnant and non-pregnant mice. TWA,
Two-way ANOVA. *Significantly different from non-pregnant mice (TWA followed by Fisher’s LSD post-test, p < 0.05). (B) Percentage CD80 positive classical,
intermediate and non-classical monocytes in pregnant and non-pregnant conventional and germfree mice. TWA, Two-way ANOVA. *Significantly different from
non-pregnant mice (TWA followed by Fisher’s LSD post-test, p < 0.05). (C) Percentage MHCII positive classical, intermediate and non-classical monocytes in
pregnant and non-pregnant conventional and germfree mice. TWA, Two-way ANOVA. *Significantly different from non-pregnant mice (TWA followed by Fisher’s LSD
post-test, p < 0.05).
all of the bacteria in cluster 4 are significantly decreased
during pregnancy.
DISCUSSION
In the present study we showed that during syngeneic pregnancy
in mice, the composition of the gut microbiota changes.
This composition has significantly changed at day 18 of
pregnancy as compared with pre-pregnancy, with for instance
an increased Firmicutes/Bacteroidetes ratio and a decreased
Shannon index. Some bacterial changes can already be observed
at day 14, for instance a significantly decreased abundance
of B. intestinihominis. We also showed that in syngeneic
conventional pregnant mice, immune responses change during
pregnancy. We observed a decreased percentage of Th1 cells
in pregnant conventional mice, as well as a trend toward an
increased percentage of Th2 cells and an increased percentage
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FIGURE 9 | Correlation between microbiota species and immune cell populations in conventional pregnant mice. The figure shows a heatmap of Spearman’s
correlations coefficients after individual correlation of significantly different microbiota species between day 18 of pregnancy and pre-pregnancy (clusters 1–4) and
immune cell populations with different adaptations in conventional vs. germfree mice (clusters A–D).
of Treg cells. Monocyte subsets also changed in conventional
syngeneic pregnant mice, with an increased percentage of
classical monocytes and a decreased percentage of non-classical
monocytes. Moreover, classical and intermediate monocytes
showed increased expression of CD80 and decreased expression
of MHCII during pregnancy in these mice. Next, we showed that
the presence of microbiota may be important in some of these
adaptations of the maternal immune response to pregnancy,
since we found different adaptations in immune cell numbers of
pregnant germfree mice compared with pregnant conventional
mice, i.e., the increase in the splenic percentage of FoxP3+
lymphocytes and the trend toward an increased Th2 percentage
was only observed in pregnant conventional mice, not in
pregnant germfree mice. Moreover, increased CD80 expression
on monocytes was only observed in conventional pregnant mice
and not in germfree pregnant mice, while decreased MHCII
expression was also only observed in conventional pregnant mice
and not in germfree pregnant mice. Finally, we correlated the gut
bacteria of conventional mice that were significantly changed at
day 18 of pregnancy with the immune cells that were significantly
changed in pregnant compared with non-pregnant mice in
conventional pregnant mice only and showed that clusters of
bacteria correlated with clusters of immune cells. Together these
data indicate that the maternal gut microbiota may be involved in
inducing some of the immunological adaptations to pregnancy.
We found various significant differences in phyla and species
abundance at day 18 of pregnancy, with an increased abundance
of Firmicutes and a decreased abundance of Bacteriodetes,
Actinobacteria, Cyanobacteria, and Proteobacteria as compared
with pre-pregnancy. At the species level, we found an increased
abundance of for instance A. stercoricanis, F. cylindroides, R.
faecis and E. plexicaudatum, Holdemanella biformis. These are all
butyrate producing Firmicutes (32). Butyrate is an short chain
fatty acid, which has immunomodulatory and anti-inflammatory
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effects (33). Butyrate can for instance promote differentiation
and proliferation of Treg (34). We found decreased abundance
of species like B. Intestinihominis and B viscericola, P. pogonae,
A. rava, O. splanchnicus as well as 2 Alistipes species. Most of
these bacteria are propionate producers (32). Propionate has
been shown to have similar effects as butyrate on the immune
response, f.i. in increasing Tregs, however, propionate has been
shown to be less effective than butyrate (35). During syngeneic
pregnancy in the mouse, there may be an increase in butyrate and
a decrease in propionate production by the gut microbiota, which
may result in increased plasma butyrate and decrease plasma
propionate and this may affect the maternal immune response.
This hypothesis needs to be tested in future studies.
The group of Koren et al. (27) was the first to show changes in
the gut microbiota during pregnancy in humans. They, however,
found an increase in Proteobacteria and Actinobacteria. Since
our study have been done in syngeneic pregnancy, differences
between our mouse study and the human study may be explained
by the presence of the semiallogeneic fetus in the human study,
as compared to syngeneic fetuses in our mouse study. Future
studies are needed to confirm this hypothesis. We only studied
one mouse strain, with one diet and at one location. However, we
are not the only group who found differences in gut microbiota
during pregnancy. Also previous studies in mice have shown
an effect of pregnancy on the abundance of gut microbiota
species (14, 36, 37). However, each of these mouse studies found
their own specific adaptations of the microbiota to pregnancy.
All of these studies have been done in syngeneic pregnancies.
Differences between the studies may be due to differences in diet
or technical differences in 16S rRNA sequencing (38). Another
factor may be genetic differences between the mouse strains,
since Elderman et al. has previously shown that changes in
the microbiota at day 18 were strain dependent (14). Although
in this study various differences in microbiota species were
found between pregnant and non-pregnant mice in the from
the BALB/c strain, no significant differences in microbiota were
found between pregnant and non-pregnant C57BL/6 mice. In
the present study, we also used C57BL/6 mice, but a different
sub strain (C57BL/6JOlaHsd), and we did find differences in
gut microbiota at day 18 of pregnancy. The difference with our
previous study may thus be the sub strain used, but also the
use of a different diet and the fact that we did a longitudinal
study, which may more easily pick up differences in microbiota.
The mechanism changing the microbiota during pregnancy
are unclear at this time. However, it has been suggested that
pregnancy hormones, like progesterone, may affect the gut
microbiota (36). Also, diet has been shown to affect the gut
microbiota (37).
In view of the known effects of the microbiota on the
immune system, we hypothesized that the microbiota during
mouse pregnancy may be involved in inducing adaptations of
the immune response to pregnancy. Therefore, we sacrificed
conventional and germfree syngeneic pregnant (at the end of
pregnancy) and non-pregnant conventional and germfree mice
and studied their immune response. In line with our previous
results and results from others, we found various adaptations in
the adaptive immune cells in syngeneic pregnant conventional
mice. We showed an increased percentage of FoxP3+ cells
and a trend toward an increase in GATA3+ cells, as well as
a decrease in the percentage of Tbet+ cells in the spleens of
conventional pregnant mice as compared to non-pregnant mice.
This is in line with various data showing that the Th1/Th2
balance is decreased in pregnancy (4, 39, 40). Also, the increase
in FoxP3+ (Treg cells) is in line with previous data (14). We,
for the first time show that also syngeneic germfree mice do
adapt their immune response to pregnancy. We found, similar
to conventional pregnant mice, a decreased percentage of Tbet+
(Th1 cells) cells in the spleens of pregnant germfree mice
as compared with non-pregnant germfree mice. However, in
contrast to conventional pregnancy mice, in germfree pregnant
mice the splenic percentage of FoxP3+ cells and GATA3+ cells
were not different compared with germfree non-pregnant mice.
This suggests that the increased splenic percentages of FoxP3+
and (trend to) increased GATA3+ cells in conventional mice at
the end of pregnancy may be induced by the gut microbiota.
This suggestion is in line with various papers indicating an
effect of several bacterial species on Treg cells and Th2 cells
(24, 25). Further studies are needed to evaluate whether the
microbiota may affect the immune response in semiallogeneic
pregnant mice.
In germfree pregnant mice, we found a slightly, but
significantly increased number of fetal resorptions and a slightly
decreased fetal weight. The mechanism of this increased number
of fetal resorptions remains unknown from the present study.
Various studies in the 1980s have shown that the housing
environment of mice is associated with different numbers
of fetal resorptions. Hamilton et al. showed that a cleaner
environment (i.e., a specific pathogen free environment vs. a
conventional environment) is associated with decreased numbers
of resorptions in allogeneic pregnancies (CBA × DBA/2) (41),
although other studies found the opposite effect (42) or no
effect of these different environments (43). In all these studies,
differences were only observed in semiallogeneic pregnancies and
not in syngeneic pregnancies, suggesting that themechanisms are
related to rejection of the semiallogeneic fetus. The mechanism
of increased fetal resorptions in germfree vs. conventional mice
in our study must therefore be different, since we used syngeneic
pregnancies. Further studies are therefore necessary to evaluate
mechanisms of the increased fetal resorption in germfree mice.
We do expect a role of the immune response, especially the
immune response in the placenta and mesometrial triangle.
Immune cells in the mesometrial triangle are very important
for normal placentation. Differences in immune cells in the
mesometrial triangle, such as decreased numbers of natural killer
cells, may result in defective placentation, and therefore in fetal
growth restriction or resorptions (44). We are evaluating the
immune cells in the mesometrial triangle in conventional vs.
germfree pregnant mice.
Individual mouse data from pregnant conventional mice
from blood immune cells and splenic immune cells that were
differently affected by pregnancy in germfree vs. conventional
mice and individual microbiota species that were different
between pregnant and non-pregnant conventional mice were
correlated and clustered. The microbiota clustered in 4 clusters.
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Cluster 1 containedmainly bacteria that were upregulated during
pregnancy, such as R. faecis, 2 Ruminococcus species and 3
Clostridium species. These bacteria positively correlated with
percentage of Treg and Th2 cells (cluster B), suggesting that
the species in this cluster may upregulate these immune cells.
Roseburia, Rumminococcus and various commensal Clostridium
species are known to produce short chain fatty acids (32, 45, 46),
which in their turn are known to induce Tregs (47). Various
bacterial species of clusters 1, 2, and 3 also correlated positively
or negatively with immune cluster D, mainly with monocytes
and lymphocytes. This suggests that the microbiota may be
involved in hematopoiesis in pregnancy. Indeed, percentages of
lymphocytes, monocytes and granulocytes are differently affected
by pregnancy in conventional and germfree mice. The effect of
the microbiota on hematopoiesis outside pregnancy has been
shown before by Josefsdottir et al. (48). Percentages of blood
monocyte subsets are affected by pregnancy, with an increase
in the percentage of classical monocytes and a decrease in
the percentage of non-classical monocytes during pregnancy in
both conventional and germfree mice. Since classical monocytes
mature in the circulation to non-classical monocytes (49), these
data may suggest a decreased maturation of monocytes during
pregnancy in these syngeneic mice. Since changes in monocyte
subsets are similar in conventional and germfree mice, the
microbiota is probably not involved and other pregnancy factors,
such as cytokines or exosomes, may be involved in inducing these
changes in monocyte subsets.
Bacterial cluster 4 contains only bacteria that were decreased
during pregnancy. They were strongly negatively correlated with
the expression of CD80 on intermediate monocytes and with
the expression of CD80 on classical monocytes. Expression of
CD80, which is an activation marker, on these monocyte subsets
increased during conventional mouse pregnancy, suggesting
that the bacteria in this cluster may normally be involved in
downregulating CD80 expression, but due to their decrease in
pregnancy, intermediate, and classical monocytesmay upregulate
CD80 expression. This cluster contains 2 Barnesiella species,
which have been shown to be anti-inflammatory in mice
(50). This suggestion of downregulation of CD80 expression
on monocytes by certain bacterial species is in line with the
fact that in non-pregnant germfree mice, CD80 expression
on intermediate monocytes is increased vs. non-pregnant
conventional mice (Figure 8B). A similar reasoning would apply
toMHC II expression on intermediate monocytes, which is down
regulated during pregnancy in conventional mice and positively
correlated with the decreased bacteria in cluster 4 suggesting
that normally these bacteria upregulate MHC II, but when these
bacteria are decreased during pregnancy, MHC II expression
is decreased.
In conclusion, our data, together with previous data in
mice and humans, indicate that the gut microbiota change
during pregnancy. The changes, however, may be species and
strain dependent, but may also depend on the diet as well
as on the method of 16S RNA sequencing. In the present
study, we found an increase in Firmicutes species (such as A.
stercoricanis) and a decrease in Bacteroidetes species (such as
B. intestihominis, B. viscericola). The gut microbiota in pregnant
mice may be involved in some of the adaptations of the maternal
immune response to pregnancy, especially in the increase in
Treg and the increased activation of monocytes at the end of
pregnancy. Although these data show that the microbiota may
be involved in inducing adaptations of the immune response to
pregnancy, these data do not show whether the change observed
in the microbiota during pregnancy are responsible for these
immunological adaptations. However, the fact that we found
various correlations between the pregnancy-induced adaptations
in immune cells and the pregnancy-induced changes in bacterial
species in conventional mice, may suggest a role for the changes
in the microbiota at day 18 of pregnancy in the adaptations of the
immune response. Further studies, such as studying the immune
response after transplantations of fecal material from pregnant
and non-pregnant conventional mice into pregnant and non-
pregnant germfree mice, are needed to confirm this hypothesis.
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